Business Description
Aarti Pharmalabs Ltd
ISIN : INE0LRU01027
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.35 | |||||
Equity-to-Asset | 0.68 | |||||
Debt-to-Equity | 0.16 | |||||
Debt-to-EBITDA | 0.73 | |||||
Interest Coverage | 18.18 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 5.12 | |||||
Beneish M-Score | -2.08 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Book Growth Rate | 1879.4 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 66.75 | |||||
9-Day RSI | 60.82 | |||||
14-Day RSI | 59.75 | |||||
6-1 Month Momentum % | 8.59 | |||||
12-1 Month Momentum % | 31.84 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.94 | |||||
Quick Ratio | 1.01 | |||||
Cash Ratio | 0.15 | |||||
Days Inventory | 220.21 | |||||
Days Sales Outstanding | 90.89 | |||||
Days Payable | 125.11 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.34 | |||||
Dividend Payout Ratio | 0.08 | |||||
Forward Dividend Yield % | 0.68 | |||||
5-Year Yield-on-Cost % | 0.34 | |||||
Shareholder Yield % | 0.49 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 44.9 | |||||
Operating Margin % | 16.88 | |||||
Net Margin % | 11.71 | |||||
FCF Margin % | 0.95 | |||||
ROE % | 13.08 | |||||
ROA % | 9.13 | |||||
ROIC % | 11.7 | |||||
ROC (Joel Greenblatt) % | 17.91 | |||||
ROCE % | 18.05 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 24.97 | |||||
PE Ratio without NRI | 24.97 | |||||
PS Ratio | 2.92 | |||||
PB Ratio | 3.08 | |||||
Price-to-Tangible-Book | 3.24 | |||||
Price-to-Free-Cash-Flow | 308.15 | |||||
Price-to-Operating-Cash-Flow | 25.05 | |||||
EV-to-EBIT | 17.77 | |||||
EV-to-EBITDA | 14.43 | |||||
EV-to-Revenue | 3.04 | |||||
EV-to-FCF | 299.62 | |||||
Price-to-Graham-Number | 1.9 | |||||
Price-to-Net-Current-Asset-Value | 10.46 | |||||
Earnings Yield (Greenblatt) % | 5.62 | |||||
FCF Yield % | 0.32 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Aarti Pharmalabs Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 18,526.2 | ||
EPS (TTM) (₹) | 23.94 | ||
Beta | 0 | ||
Volatility % | 43.45 | ||
14-Day RSI | 59.75 | ||
14-Day ATR (₹) | 28.840147 | ||
20-Day SMA (₹) | 588.955 | ||
12-1 Month Momentum % | 31.84 | ||
52-Week Range (₹) | 320.3 - 638.75 | ||
Shares Outstanding (Mil) | 90.63 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Aarti Pharmalabs Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Aarti Pharmalabs Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Aarti Pharmalabs Ltd Frequently Asked Questions
What is Aarti Pharmalabs Ltd(NSE:AARTIPHARM)'s stock price today?
When is next earnings date of Aarti Pharmalabs Ltd(NSE:AARTIPHARM)?
Does Aarti Pharmalabs Ltd(NSE:AARTIPHARM) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |